Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-24 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award +25,800 82,090
2021-02-24 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award · Employee Stock Option (Right to Buy) +61,200 61,200
2021-02-24 Polymeropoulos Mihael Hristos President and CEO Grant or award +115,000 1,418,747
2021-02-24 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +275,000 275,000
2021-02-24 Moran Kevin Patrick SVP, CFO & Treasurer Grant or award +32,700 110,797
2021-02-24 Moran Kevin Patrick SVP, CFO & Treasurer Grant or award · Employee Stock Option (Right to Buy) +77,500 77,500
2021-02-24 Jones Aranthan II Chief Corp. Affairs Officer Grant or award +25,800 101,287
2021-02-24 Jones Aranthan II Chief Corp. Affairs Officer Option exercise +22,499 $12.27 $276K 123,786
2021-02-24 Jones Aranthan II Chief Corp. Affairs Officer Sale −22,986 $20.01 $460K 100,800
2021-02-24 Jones Aranthan II Chief Corp. Affairs Officer Grant or award · Employee Stock Option (Right to Buy) +61,200 61,200
2021-02-24 Jones Aranthan II Chief Corp. Affairs Officer Option exercise · Employee Stock Option (Right to Buy) −22,499 37,501
2021-02-24 Birznieks Gunther SVP, Business Development Grant or award +32,700 192,173
2021-02-24 Birznieks Gunther SVP, Business Development Grant or award · Employee Stock Option (Right to Buy) +77,500 77,500
2021-02-16 Watkins Thomas Director Option exercise +15,000 $7.11 $107K 55,323
2021-02-16 Watkins Thomas Director Sale −5,818 $18.54 $108K 49,505
2021-02-16 Watkins Thomas Director Option exercise · Stock Option (Right to Buy) −15,000 0
2021-02-16 DUGAN RICHARD W Director Option exercise +15,000 $7.11 $107K 60,641
2021-02-16 DUGAN RICHARD W Director Sale −5,754 $18.54 $107K 54,887
2021-02-16 DUGAN RICHARD W Director Option exercise · Stock Option (Right to Buy) −15,000 0
2020-12-15 Polymeropoulos Mihael Hristos President and CEO Option exercise +46,663 $8.75 $408K 1,342,897

Page 12 of 20 · 387 trades